Administration of Methylene Blue in Septic Shock: Is it Beneficial?

  • J. C. Preiser
  • H. Zhang
  • J. L. Vincent
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine 1994 book series (YEARBOOK, volume 1994)

Abstract

Nitric oxide (NO) is released in massive amounts following exposure of isolated vessels, isolated organs or intact animals to a septic challenge, represented by bacterial lipopolysaccharide (LPS), exotoxin, cytokines, or supernatant from activated neutrophils or macrophages. By its potent vasodilating action, and also its negative inotropic effects, NO has been incriminated in the hemodynamic disturbances of severe sepsis or septic shock. However, NO also plays a role in the maintenance of peripheral tissue perfusion (through vascular relaxation and inhibition of platelet aggregation), in the intercellular adhesion and in the macrophage-mediated response to some microorganisms and tumors.

Keywords

Adenosine Serotonin Norepinephrine Cyanide Catechol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cobb JP, Natanson C, Hoffman WD et al, (1992) N-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176: 1175–1182PubMedCrossRefGoogle Scholar
  2. 2.
    Wright CH, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26: 48–57PubMedCrossRefGoogle Scholar
  3. 3.
    Ochoa JB, Udekwu AO, Billiar TR et al, (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214: 621–626PubMedCrossRefGoogle Scholar
  4. 4.
    Evans T, Carpenter A, Kinderman H, Cohen J (1993) Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41: 77–81PubMedGoogle Scholar
  5. 5.
    Schneider F, Lutun P, Couchot A, Bilbault P, Tempé JD (1993) Plasma cyclic guanosine 3’-5’ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 19: 99–104PubMedCrossRefGoogle Scholar
  6. 6.
    Hibbs JB, Westenfelder C, Taintor R, et al (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89: 867–877PubMedCrossRefGoogle Scholar
  7. 7.
    Petros A, Bennett D, Valiance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558PubMedCrossRefGoogle Scholar
  8. 8.
    Lorente JA, Landin L, De Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287–1295PubMedCrossRefGoogle Scholar
  9. 9.
    McMahon TJ, Kadowitz PJ (1992) Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the cat. Am J Physiol 263: L575 — L584PubMedGoogle Scholar
  10. 10.
    Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A (1993) EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB 7: 1124–1134Google Scholar
  11. 11.
    Martindale (1989) The extra pharmacopoeia. The Pharmaceutical Press, London Ed. 29 pp 843–844Google Scholar
  12. 12.
    Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ (1981) Relationship between cyclic guanosine 3’:5’-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 219: 181–186Google Scholar
  13. 13.
    Chen X, Gillis CN (1993) Methylene blue enhanced photorelaxation in aorta, pulmonary artery and corpus cavernosum. Biochem Biophys Res Commun 190: 559–563PubMedCrossRefGoogle Scholar
  14. 14.
    Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45: 367–374PubMedCrossRefGoogle Scholar
  15. 15.
    Wong SK, Garbers DL (1992) Receptor guanylyl cyclases. J Clin Invest 90: 299–305PubMedCrossRefGoogle Scholar
  16. 16.
    Tranquada RE, Bernstein S, Grant WJ (1963) Methylene blue in the treatment of lactic acidosis. Clin Res 11: 230–235Google Scholar
  17. 17.
    Schick PK, Yu BP (1973) Methylene blue-induced serotonin release in human platelets. J Lab Clin Med 82: 546–553PubMedGoogle Scholar
  18. 18.
    Cronholm T (1993) Ethanol metabolism in isolated hepatocytes. Effects of methylene blue, cyanamide and penicillamine on the redox state of the bound coenzyme and on the substrate exchange at alcohol dehydrogenase. Biochem Pharmacol 45: 553–558PubMedCrossRefGoogle Scholar
  19. 19.
    Martin W, Drazan KM, Newby AC (1989) Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Br J Pharmacol 97: 51–56PubMedGoogle Scholar
  20. 20.
    Gruetter CA, Kadowitz PJ, Ignarro LT (1981) Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol 59: 150–156PubMedCrossRefGoogle Scholar
  21. 21.
    Ignarro LJ, Lippton H, Edwards JC, et al (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 739–749Google Scholar
  22. 22.
    Martin W, Villani GM, Jothianandan D, Furchgott RF (1985) Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232: 708–716PubMedGoogle Scholar
  23. 23.
    Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376PubMedCrossRefGoogle Scholar
  24. 24.
    Boulanger C, Schini VB, Moncada S, Vanhoutte PM (1990) Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br J Pharmacol 101: 152–156PubMedGoogle Scholar
  25. 25.
    Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526PubMedCrossRefGoogle Scholar
  26. 26.
    Moritoki H, Ueda H, Yamamoto T, Hisayama T, Takeuchin S (1991) L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation. Br J Pharmacol 102: 841–846PubMedGoogle Scholar
  27. 27.
    Moritoki H, Hisayama T, Takeuchi S, Miyano H, Kondoh W (1992) Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br J Pharmacol 107: 196–201PubMedGoogle Scholar
  28. 28.
    Komas N, Lugnier C, Stoclet JC (1991) Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104: 495–503PubMedGoogle Scholar
  29. 29.
    Morley D, Maragos CM, Zhang XY, Boignon M, Wink DA, Keefer LK (1993) Mechanism of vascular relaxation induced by the nitric oxide ( NO)/nucleophile complexes, a new class of NO-based vasodilators. J Cardiovasc Pharmacol 21: 670–676Google Scholar
  30. 30.
    Topouzis, S, Schott C, Stoclet JC (1991) Participation of endothelium-derived relaxing factor and role of cyclic GMP alpha-adrenoreceptor agonists in rat aorta. J Cardiovasc Pharmacol 18: 670–678PubMedCrossRefGoogle Scholar
  31. 31.
    Grser T, Rubanyi GM (1992) Different mechanisms of hypoxic relaxation in canine coronary arteries and rat abdominal aortas. J Cardiovasc Pharmacol 20: S117 - S119PubMedGoogle Scholar
  32. 32.
    Simonet S, Porro-de-Bailliencourt J, Descombes JJ, Mennecier P, Laubie M, Verbeuren TJ (1993) Hypoxia causes an abnormal contractile response in the atherosclerotic rabbit aorta. Circ Res 72: 616–630PubMedGoogle Scholar
  33. 33.
    Yu XJ, Li YJ, Deng HW (1993) The regulatory effect of bradykinin on the actions of sensory nerves in the perfused rat mesentery is mediated by nitric oxide. Eur J Pharmacol 241: 35–40PubMedCrossRefGoogle Scholar
  34. 34.
    Qi X, Chen D, Nottin R, Mace L, Herve P, Weiss M (1993) Evidence of L-arginine/nitric oxide pathway in endothelium and smooth muscle of human internal mammary artery. Biochem Biophys Res Commun 195: 90–96PubMedCrossRefGoogle Scholar
  35. 35.
    Watanabe M, Rosenblum WI, Nelson GH (1988) In vivo effect of methylene blue on endothelium-dependent and endothelium-independent dilations of brain microvessels in mice. Circ Res 62: 86–90PubMedGoogle Scholar
  36. 36.
    Iwamoto J, Yoshinaga M, Yang SP, Krasney E, Krasney J (1992) Methylene blue inhibits hypoxic cerebral vasodilation in awake sheep. J Appl Physiol 73: 2226–2232PubMedGoogle Scholar
  37. 37.
    Gold ME, Wood KS, Byrns RE, Buga GM, Ignarro LT (1990) L-arginine-dependent vascular smooth muscle relaxation and cGMP formation. Am J Physiol 259: H1813 - H1821PubMedGoogle Scholar
  38. 38.
    Wood KS, Buga GM, Byrns RE, Ignarro LT (1990) Vascular smooth muscle-derived relaxing factor ( MDRF) and its close similarity to nitric oxide. Biochem Biophys Res Commun 170: 80–88PubMedCrossRefGoogle Scholar
  39. 39.
    Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ (1986) Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. J Pharmacol Exp Ther 236: 30–35PubMedGoogle Scholar
  40. 40.
    Hyman AL, Kadowitz PJ, Lippton HL (1989) Methylene blue selectively inhibits pulmonary vasodilator responses in cats. J Appl Physiol 66: 1513–1517PubMedCrossRefGoogle Scholar
  41. 41.
    McMahon TJ, Ignarro LJ, Kadowitz PJ (1993) Influence of zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 74: 1704–1711PubMedGoogle Scholar
  42. 42.
    Rodman DM, Yamaguchi T, Hasunuma K, O’Brien RF, McMurtry IF (1990) Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery. Am J Physiol 258: L207 - L214PubMedGoogle Scholar
  43. 43.
    Mazmanian GM, Baudet B, Brink C, Cerrina J, Kirkiacharian S, Weiss M (1989) Methylene blue potentiates vascular reactivity in isolated rat lungs. J Appl Physiol 66: 10401045Google Scholar
  44. 44.
    Tseng CM, Mitzner W (1992) Antagonists of EDRF attenuate acetylcholine-induced vasodilation in isolated hamster lungs. J Appl Physiol 72: 2162–2167PubMedGoogle Scholar
  45. 45.
    Ogata M, Ohe M, Katayose D, Takishima T (1992) Modulatory role of EDRF in hypoxic contraction of isolated porcine pulmonary arteries. Am J Physiol 262: H691 - H697PubMedGoogle Scholar
  46. 46.
    Rimar S, Gillis CN (1992) Pulmonary vasodilation by inhaled nitric oxide after endothelial injury. J Appl Physiol 73: 2179–2183PubMedGoogle Scholar
  47. 47.
    Tschudi M, Richard V, Bühler FR, Löscher TF (1991) Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 260: H13 - H20PubMedGoogle Scholar
  48. 48.
    Cowan CL, Cohen RA (1991) Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses. Am J Physiol 261: H830 - H835PubMedGoogle Scholar
  49. 49.
    Gräser T, Vanhoutte PM (1991) Hypoxic contraction of canine coronary arteries: Role of endothelium and cGMP. Am J Physiol 261: H1769 - H1777PubMedGoogle Scholar
  50. 50.
    Ziche M, Morbidelli L, Masine E, Granger H, Geppetti P, Ledda F (1993) Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 192: 1198–1203PubMedCrossRefGoogle Scholar
  51. 51.
    Bucher B, Ouedraogo S, Tschöpl M, Paya D, Stoclet JC (1992) Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol 107: 976–982PubMedGoogle Scholar
  52. 52.
    Auberson S, Lacroix JS, Morel DR, Lehmann W, Lundberg TM (1991) Methylene blue attenuates vasodilatation and enhances vasoconstriction in response to endothelin-1 in the pig nasal mucosa. Acta Physiol Scand 142: 149–156PubMedCrossRefGoogle Scholar
  53. 53.
    Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G (1990) Methylene blue inhibits vasodilatation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 254: 872–876PubMedGoogle Scholar
  54. 54.
    Azadzoi KM, Kim N, Brown ML, Goldstein I, Cohen RA, Saenz de Tejada I (1992) Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 147: 220–225Google Scholar
  55. 55.
    Andrade SP, Hart IR, Piper PJ (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol 107: 1092–1095PubMedGoogle Scholar
  56. 56.
    Weber AA, Strobach H, Schrör K (1993) Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 247: 29–37PubMedCrossRefGoogle Scholar
  57. 57.
    Beasley D (1990) Interleukin-1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 259: R38 — R44PubMedGoogle Scholar
  58. 58.
    Beasley D, Schwartz JH, Brenner BM (1991) Interleukin 1 induces prolonged L-argininedependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 87: 602–608PubMedCrossRefGoogle Scholar
  59. 59.
    Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet JC (1990) Incúbation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 171: 562–568PubMedCrossRefGoogle Scholar
  60. 60.
    Gray GA, Julou-Schaeffer G, Oury K, Fleming I, Parratt JR, Stoclet IC (1990) An Larginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium. Eur J Pharmacol 191: 89–92PubMedCrossRefGoogle Scholar
  61. 61.
    Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stoclet JC (1991) Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol 103: 1047–1052PubMedGoogle Scholar
  62. 62.
    Fleming I, Gray GA, Stoclet JC (1993) Influence of endothelium on induction of the Larginine-nitric oxide pathway in rat aortas. Am J Physiol 264: H1200 — H1207PubMedGoogle Scholar
  63. 63.
    Schott CA, Gray GA, Stoclet JC (1993) Dependence of endotoxin-induced vascular hypo-reactivity on extracellular L-arginine. Br J Pharmacol 108: 38–43PubMedGoogle Scholar
  64. 64.
    Schneider F, Schott C, Stoclet JC, Julou-Schaeffer G (1992) L-arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats. Eur J Pharmacol 211: 269–272PubMedCrossRefGoogle Scholar
  65. 65.
    Auguet M, Guillon JM, Delaflotte S, Etiemble E, Chabrier PE, Braquet P (1990) Endothelium independent protective effect of N°-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivity. Life Sci 48: 189–193CrossRefGoogle Scholar
  66. 66.
    Auguet M, Lonchampt MO, Delaflotte S, Goulin-Schulz J, Chabrier PE (1992) Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS 297: 183–185CrossRefGoogle Scholar
  67. 67.
    Baker C, Sutton ET (1993) Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am J Physiol 264: H1118 — H1123PubMedGoogle Scholar
  68. 68.
    Ueno M, Lee TJ (1993) Endotoxin decreases the contractile responses of the porcine basilar artery to vasoactive substances. J Cereb Blood Flow Metab 13: 712–719PubMedCrossRefGoogle Scholar
  69. 69.
    Salvemini D, Mollace V, Pistelli A, Anggard E, Vane J (1992) Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 89: 982–986PubMedCrossRefGoogle Scholar
  70. 70.
    Rimele TJ, Armstrong SJ, Grimes D, Sturm RI (1991) Rat peritoneal neutrophils selectively relax vascular smooth muscle. J Pharmacol Exp Ther 258: 963–971PubMedGoogle Scholar
  71. 71.
    Kadota K, Yui Y, Hattori R, Uchizumi H, Kawai C (1991) A new relaxing factor in supernatant of incubated rat peritoneal neutrophils. Am J Physiol 260: H967 — H972PubMedGoogle Scholar
  72. 72.
    Johnson A, Ferro TT (1992) TNF-alpha augments pulmonary vasoconstriction via the inhibition of nitrovasodilator activity. J Appl Physiol 73: 2483–2492PubMedGoogle Scholar
  73. 73.
    Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176 — H182PubMedGoogle Scholar
  74. 74.
    Schulz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a Cat±-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575–580PubMedGoogle Scholar
  75. 75.
    Balligand JL, Ungureanu D, Kelly RA, et al (1993) Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314–2319PubMedCrossRefGoogle Scholar
  76. 76.
    Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387–389PubMedCrossRefGoogle Scholar
  77. 77.
    Arnal JF, Schott C, Stoclet JC, Michel JB (1993) Vascular relaxation and cyclic guanidine monophosphate in a rat model of high output heart failure. Cardiovasc Res 27: 16511656Google Scholar
  78. 78.
    Durante W, Schini VB, Scott-Burden T, et al (1991) Platelet inhibition by an L-argininederived substance released by IL-113-treated vascular smooth muscle cells. Am J Physiol 261: H2024 — H2030PubMedGoogle Scholar
  79. 79.
    Petit JF, Schott C, Lepoivre M, Stoclet JC (1990) Production of an arginine-derived relaxing factor induced by IFN-gamma plus endotoxin in murine adenocarcinoma EMT 6 cells. Biochem Biophys Res Commun 173: 1–5PubMedCrossRefGoogle Scholar
  80. 80.
    Paya D, Gray GA, Stoclet JC (1993) Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats. J Cardiovasc Pharmacol 21: 926–930PubMedCrossRefGoogle Scholar
  81. 80.
    Paya D, Gray GA, Stoclet JC (1993) Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats. J Cardiovasc Pharmacol 21: 926–930PubMedCrossRefGoogle Scholar
  82. 82.
    Birch AA, Boyce WH (1976) Hypertension and decreased renal blood flow following methylene blue injection. Anesth Analg 55: 674–676PubMedCrossRefGoogle Scholar
  83. 83.
    Schneider F, Lutun P, Hasselmann M, Stoclet JC (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18: 309–311CrossRefGoogle Scholar
  84. 83.
    Schneider F, Lutun P, Hasselmann M, Stoclet JC (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18: 309–311CrossRefGoogle Scholar
  85. 84.
    Preiser JC, Lejeune P, Roman A, et al (1994) Methylene blue in septic shock: A clinical trial. Crit Care Med (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • J. C. Preiser
  • H. Zhang
  • J. L. Vincent

There are no affiliations available

Personalised recommendations